Data / Form D filings / EyeMacular Regeneration, Inc.
EyeMacular Regeneration, Inc.: Form D filings
EyeMacular Regeneration, Inc., a biotechnology company in St. Paul, MN, filed 3 Form D notices with the SEC between 2024 and 2026. The latest, on September 25, 2026, reports $2.9 million sold of a $6 million offering to 14 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1000 WESTGATE DR. STE 113, St. Paul, MN, 55114
- Phone
- (404) 290-6418
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2023
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2042485
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 25, 2026 | Amendment | $6,000,000 | $2,870,000 | $3,130,000 | 14 | Oct 8, 2024 | sec.gov |
| Oct 9, 2025 | Amendment | $6,000,000 | $2,000,000 | $4,000,000 | 12 | Oct 8, 2024 | sec.gov |
| Oct 24, 2024 | New notice | $6,000,000 | $600,000 | $5,400,000 | 1 | Oct 8, 2024 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Timothy W Olsen | Executive Officer, Director | Dr. Olsen is the Chief Executive Officer and Chair of the Board of Directors. |
| Virginia Olsen | Executive Officer | Virginia Olsen is Secretary and Chief Human Capital Officer |
| Gerald R. Benjamin | Director | Mr. Benjamin serves on the Board of Directors |
| Richard L. Lindstrom | Director | Dr. Lindstrom serves on the Board of Directors |
| David M. Brown | Director | Dr. Brown serves on the Board of Directors |
| Michael Lindsay Olsen | Director | Mr. Olsen serves on the Board of Directors |
| David C. Herman | Director | Dr. Herman serves as a Director |
Other biotechnology companies in Minnesota that filed recently
- Medical 21, Inc. $550,000 · Oct 23, 2026
- InSitu Biologics, Inc. $1.3 million · Oct 14, 2026
- Evia Bio, Inc. $5.5 million · Sep 28, 2026
- ProEncia Biotechnology Inc. $1.5 million · Aug 26, 2026
Every Form D from the week of Sep 21, 2026 · All recent filings in Minnesota · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EyeMacular Regeneration, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.